These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 10400908)

  • 1. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
    Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
    Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
    Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
    J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
    Feron O; Michel JB; Sase K; Michel T
    Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-induced permeability increase is mediated by caveolae.
    Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.
    Lungu AO; Jin ZG; Yamawaki H; Tanimoto T; Wong C; Berk BC
    J Biol Chem; 2004 Nov; 279(47):48794-800. PubMed ID: 15383526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
    Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
    J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
    Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T
    J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production.
    Heijnen HF; Waaijenborg S; Crapo JD; Bowler RP; Akkerman JW; Slot JW
    J Histochem Cytochem; 2004 Oct; 52(10):1277-85. PubMed ID: 15385574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association.
    Rizzo V; McIntosh DP; Oh P; Schnitzer JE
    J Biol Chem; 1998 Dec; 273(52):34724-9. PubMed ID: 9856995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O; Dessy C; Desager JP; Balligand JL
    Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles.
    Govers R; van der Sluijs P; van Donselaar E; Slot JW; Rabelink TJ
    J Histochem Cytochem; 2002 Jun; 50(6):779-88. PubMed ID: 12019294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling.
    García-Cardeña G; Oh P; Liu J; Schnitzer JE; Sessa WC
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6448-53. PubMed ID: 8692835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.
    Uittenbogaard A; Shaul PW; Yuhanna IS; Blair A; Smart EJ
    J Biol Chem; 2000 Apr; 275(15):11278-83. PubMed ID: 10753938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
    Feron O; Saldana F; Michel JB; Michel T
    J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.
    Schwartz EA; Reaven E; Topper JN; Tsao PS
    Biochem J; 2005 Aug; 390(Pt 1):199-206. PubMed ID: 15819614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
    Blair A; Shaul PW; Yuhanna IS; Conrad PA; Smart EJ
    J Biol Chem; 1999 Nov; 274(45):32512-9. PubMed ID: 10542298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting and translocation of endothelial nitric oxide synthase.
    Michel T
    Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced caveolae density in arteries of SHR contributes to endothelial dysfunction and ROS production.
    Potje SR; Grando MD; Chignalia AZ; Antoniali C; Bendhack LM
    Sci Rep; 2019 Apr; 9(1):6696. PubMed ID: 31040342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.